INTRODUCTION
The noble gases helium, neon, argon, krypton, xenon and radon are odourless, colourless, these gases are already frequently used in medicine, e.g. helium is applied to patients with severe airway disease because of its very low density. 1, 2 Xenon has been shown to act at the N-methyl-D-aspartate receptor 3 thereby inducing anaesthesia under normobaric conditions. periods of ischemia-reperfusion, e.g. when the gas was applied before organ ischemia as an early or late preconditioning stimulus, [9] [10] [11] after ischaemia as a postconditioning stimulus, 12, 13 or when given in combination before, during and/or after ischemia. 14 A wide range of organs can be protected by these inert substances, in particular the heart and neuronal tissue. 6, 8, 15 This article will summarize the current knowledge of noble-gas induced cardio-protection and will focus on the mechanisms of protection and a possible translatability to the clinical situation.
XENON

Cardioprotection by xenon
Anaesthetic properties of xenon have been described as early as 1951, 16 and during the last two decades numerous studies evaluated molecular properties 8 and clinical advantages 17 of xenon as an anaesthetic agent. Within the on-going discussion on anesthesia-induced postoperative cognitive dysfunction in the elderly surgical patient, xenon might be advantageous compared to commonly used inhalational anesthetics, 18, 19 been challenged by other investigators.
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By far, most information on organ protection by noble gases comes from studies using xenon as an inhalational agent. Experimental studies clearly showed protection of the brain, 21 spinal cord, 22, 23 kidney, 24 heart 11, 25 and vascular endothelium 26 against ischemia-reperfusion injury by xenon.
post-conditioning.
In rabbits subjected to 30 min of coronary artery occlusion followed by 120 min of reperfusion, inhalation of xenon (70%) at the very end of regional myocardial ischemia and during the post-conditioning) reduced infarct size. 27 Post-conditioning by sub-anaesthetic concentrations of xenon (20%) combined with mild hypothermia during early reperfusion also reduced myocardial damage in rats in vivo. 28 
20
Much more information is available for myocardial pre-conditioning with xenon. Cardioprotection by xenon might be established if the gas is given as an early (within 2-3 h) or late (within 12-24 h) pre-conditioning stimulus before organ ischemia occurs: in rats subjected to 25 min of regional myocardial ischaemia followed by 2 h of reperfusion, xenon inhalation for the area at risk to 28%.
11
Mechanisms of xenon induced cardioprotection
There are numerous enzymes and cellular structures involved in mediating the organ protec-29 the Janus kinase (JAK), the signal transducer and activator of transcription (STAT) and the intracellular mediators, like e.g. phosphatidylinositol 3 kinase (PI3K), protein kinase c (PKC), -29 It is likely that these pathways, which have mainly been described for ischemic conditioning, 30 gases.
summarizes the possible mechanisms of noble gas induced cardio protection.
Mechanism of xenon early preconditioning
The infarct size reduction by xenon pre-conditioning 11 was completely blocked by infusion of a protein kinase C (PKC) inhibitor or a p38 mitogen-activated protein kinase (MAPK) inhibitor, blocked by the PKC inhibitor but not by the MAPK inhibitor. These data show that p38 MAPK is located downstream of PKC in the signalling cascade of xenon-induced pre-conditioning.
blocked by a PKC inhibitor) and that the downstream target of p38 MAPK, the MAPK-activated protein kinase 2 (MAPKAPK-2) is also phosphorylated after xenon preconditioning. 
Mechanism of xenon late preconditioning
A second window of protection (late preconditioning, LPC) occurs 12-24 h after application of a preconditioning stimulus and lasts up to 72 h. Xenon-induced LPC reduced infarct size in rat hearts subjected to regional ischemia and reperfusion from 64% to 31% of the area at risk.
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Co-administration of an inhibitor of cyclooxygenase 2 (COX-2) completely blocked this infarct protein expression observed after xenon preconditioning.
Endothelial protection by xenon
An endothelial layer covers all vessels in the body, including coronary artery vessels. Cardiovia changes within the endothelium. The endothelial cell surface is relatively non-adhesive for macromolecular structures, the expression of cell adhesion molecules (CAM) on the endothelial layer, thereby recruiting has been shown that xenon competes with the co-agonist glycine at the glycine site of the N-methyl-D-aspartate receptor.
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Translatability of xenon-related organ protection
Xenon limited cell loss and decreased caspase-3 activity in cultured human osteosarcoma 47 In cultured renal tubular cells (HK-2 cells) subjected to oxygen and glucose deprivation, xenon was the only noble gas with cell-protective properties. 48 In this cell type, subjected to hypoxia-hypothermia, xenon limited cell loss and promoted cell expression of HSP-70 and haemeoxygenase-1. 49 In an isolated cardiopulmonary animal studies are translatable to the clinical situation in humans. xenon in co-morbid or elderly patients, although this group of patients would most likely be the most relevant population for organ protection.
HELIUM
In contrast to xenon, the noble gas helium has no anesthetic properties, and might therefore be used in awake patients subjected to ischemia-reperfusion situations, e.g. during percutaneous coronary interventions in patients with myocardial infarction.
cause helium has a low density, it reduces work of breathing and is therefore used in patients with airway diseases. Ventilators allowing application of helium by invasive and non-invasive ventilation strategies are available, and therefore helium might also be used during heart or vascular surgery, or in patients undergoing organ transplantation. Because this noble gas is much less expensive, helium might be an excellent alternative for organ protection in clinical ischemia-reperfusion situations.
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Mechanisms of cardioprotection induced by helium
Preconditioning by helium
Besides xenon, also the non-anesthetic noble gas helium exerts profound organ-protective 69 Three times 5 minutes inhalation of 70% helium before 30 minutes of coronary artery 70 These data show that the noble gas helium induces preconditioning of the heart.
Administration of a phosphatyldylinositosol-3-kinase ((PI3K) antagonist, a mitogen/extracellular signal-related kinase 1 (MEK-1) inhibitor or an inhibitor of the 70-kDa ribosomal protein s6 kinase (p70s6kinase) abolished this helium-induced preconditioning, indicating a cardio-protection. As these pro-survival kinases inhibit glycogen synthase kinase 3b (GSK-3b) and apoptotic protein p53 degradation, Pagel et al. investigated whether inhibition of GSK3b and p53 lowers the threshold of helium-induced protection. 71 The authors could indeed demonstrate that with these pharmacological interventions the protection of helium could be 72 These data indicate an opioid-receptor mediated mechanism in helium-induced preconditioning which might play used opioid analgesic applied in these clinical situations.
Opening of the mitochondrial permeability transition pore (mPTP) leads to mitochondrial the mPTP. 73 Application of a selective mPTP opener abolished helium-induced early preconditioning, 71 indicating that helium eventually inhibits mPTP opening. Prolongation of postischemic acidosis has been shown to reduce myocardial infarct size, 74 and correction of acidic 75 thereby inducing tissue damage.
Transient alkalosis during early reperfusion abolished helium-induced cardio-protection, but the protection was restored by the mPTP inhibitor Cyclosporine A. 76 These data suggest that helium prevents mPTP opening by maintaining intracellular acidosis during early reperfusion. and genes involved in autophagy (24 of 32) was up regulated after helium postconditioning.
These data suggest that helium postconditioning at least partly abrogates execution of cell death programs thereby reducing myocardial infarct size.
myocardium. However, pathophysiological changes, e.g. hypertension, diabetes mellitus or diseased animals: it is abolished in aged rats 79, 80 as well as in diabetic, Zucker obese rats. 12 The combination of both, helium pre-with post-conditioning, was protective against infarct size development in spontaneous hypertensive rats, whereas each stimulus alone was not able to induce cardioprotection in the hypertensive rat heart. 14 
E ect of helium on caveolae and caveolins
Caveolae are cholesterol and sphingolipid enriched invaginations of the plasma membrane.
Caveolins, the structural proteins essential for caveolae formation, are critically involved in anaesthetic-induced cardio-protection. 82 Helium inhalation decreased Caveolin-1 and 3
expressions after 24 h. 
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